Idexx Laboratories (IDXX) Share-based Compensation (2009 - 2026)

Idexx Laboratories' Share-based Compensation history runs 18 years deep, the most recent figure standing at $16.3 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 166.82% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $70.2 million (up 986.13% YoY), while the FY2025 annual figure was $60.0 million, up 469.87% from the prior year.
• Share-based Compensation for Q1 2026 stood at $16.3 million, up from $16.1 million in the prior quarter.
• The five-year high for Share-based Compensation was $26.1 million in Q3 2022, with the low at -$35.5 million in Q4 2024.
• The 5-year median for Share-based Compensation is $10.2 million (2024), against an average of $6.3 million.
• Peak annual rise in Share-based Compensation reached 25127.85% in 2024, while the deepest fall reached 52314.71% in 2024.
• Idexx Laboratories' Share-based Compensation stood at -$25.9 million in 2022, then soared by 100.26% to $68000.0 in 2023, then tumbled by 52314.71% to -$35.5 million in 2024, then jumped by 145.38% to $16.1 million in 2025, then rose by 1.42% to $16.3 million in 2026.
• Business Quant data shows IDXX's Share-based Compensation at $16.3 million in Q1 2026, $16.1 million in Q4 2025, and $14.4 million in Q3 2025.